1,481
Participants
Start Date
December 5, 2016
Primary Completion Date
March 18, 2020
Study Completion Date
August 26, 2020
Rivaroxaban (Xarelto, BAY59-7939)
As prescribed by the treating physician
Multiple Locations
Lead Sponsor
Janssen Research & Development, LLC
INDUSTRY
Bayer
INDUSTRY